This article is more than 5 years old. Information may no longer be current.

VIDEO: A 'new wave of innovation' for CLI

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LAS VEGAS — In this video exclusive, Jihad A. Mustapha, MD, FACC, FSCAI, highlights results of the anticipated Lutonix BTK study showing safety and efficacy of a drug-coated balloon in below-the-knee lesions.

The randomized trial, presented by Mustapha at VIVA 18, compared outcomes with the Lutonix 014 DCB (BD) and percutaneous transluminal angioplasty in patients with narrowed or obstructed arteries below the knee.

“I’m hoping to see a real iteration and a whole new wave of innovation and hope … for new drug-coated balloon technologies in research and development … for critical limb ischemia, because critical limb ischemia isn’t going anywhere so we’ve got to find multiple methods to treat it,” Mustapha, CLI specialist at Advanced Cardiac and Vascular Amputation Prevention Centers in Grand Rapids, Michigan, told Cardiology Today’s Intervention.

Watch the video for more.